(株)Ｖｅｒｉｔａｓ Ｉｎ Ｓｉｌｉｃｏの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 130A/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2026/08/14 | 日証協 | 261,300株 | 0.00% | 100株 | -75.00% | 374,946株 | 0.00% | 900株 | -80.85% |
| 2026/08/07 | 日証協 | 0株 | 0.00% | 400株 | -97.65% | 0株 | 0.00% | 4,700株 | -59.49% |
| 2026/07/31 | 日証協 | 263,500株 | -2.91% | 17,000株 | 0.00% | 379,146株 | -2.79% | 11,601株 | +866.75% |
| 2026/07/24 | 日証協 | 271,400株 | -0.59% | 0株 | -100.00% | 390,046株 | +0.21% | 1,200株 | -70.01% |
| 2026/07/17 | 日証協 | 273,000株 | -1.12% | 400株 | -87.10% | 389,245株 | +0.03% | 4,001株 | -18.35% |
| 2026/07/10 | 日証協 | 276,100株 | -5.35% | 3,100株 | -47.46% | 389,145株 | -3.02% | 4,900株 | -88.76% |
| 2026/07/03 | 日証協 | 291,700株 | -1.62% | 5,900株 | +293.33% | 401,245株 | -0.64% | 43,590株 | +1017.69% |
| 2026/06/26 | 日証協 | 296,500株 | -31.71% | 1,500株 | -68.09% | 403,845株 | -15.59% | 3,900株 | -41.03% |
| 2026/06/19 | 日証協 | 434,200株 | -1.30% | 4,700株 | -28.79% | 478,454株 | -0.06% | 6,614株 | -40.95% |
| 2026/06/12 | 日証協 | 439,900株 | -1.23% | 6,600株 | +186.96% | 478,740株 | -0.33% | 11,200株 | +229.41% |
| 2026/06/05 | 日証協 | 445,400株 | -10.85% | 2,300株 | -91.81% | 480,340株 | -6.56% | 3,400株 | -76.57% |
| 2026/05/29 | 日証協 | 499,600株 | -5.11% | 28,100株 | +1773.33% | 514,049株 | -4.01% | 14,509株 | +81.36% |
| 2026/05/22 | 日証協 | 526,500株 | -4.19% | 1,500株 | 0.00% | 535,549株 | -3.37% | 8,000株 | +263.64% |
| 2026/05/15 | 日証協 | 549,500株 | -0.11% | 0株 | -100.00% | 554,249株 | -0.38% | 2,200株 | -21.43% |
| 2026/05/08 | 日証協 | 550,100株 | +0.16% | 1,200株 | +300.00% | 556,349株 | 0.00% | 2,800株 | -40.43% |
| 2026/05/01 | 日証協 | 549,200株 | -0.62% | 300株 | -97.89% | 556,349株 | -0.29% | 4,700株 | -91.68% |
| 2026/04/24 | 日証協 | 552,600株 | -5.97% | 14,200株 | -18.86% | 557,949株 | -2.87% | 56,500株 | +304.18% |
| 2026/04/17 | 日証協 | 587,670株 | -3.66% | 17,500株 | +29.63% | 574,410株 | -1.90% | 13,979株 | +203.89% |
| 2026/04/10 | 日証協 | 609,970株 | -8.50% | 13,500株 | +1250.00% | 585,540株 | -4.83% | 4,600株 | +322.02% |
※株式分割は考慮していませんのでご注意ください。
Page Top